Emtricitabin / Tenofovirdisoproxil (PrEP)
Film-coated tablet containing emtricitabine 200 mg and tenofovir disoproxil 245 mg for HIV prevention (PrEP).
- WirkeintrittOnsetDélai d’actionWerkingsaanvang
- only after several days of regular intake
- WirkdauerDurationDurée d’actionWerkingsduur
- as long as the daily intake is regular
- FormFormFormeVorm
- Film-coated tablets
So wirkt es:How it works:Mode d’action :Zo werkt het: Both drugs belong to the class of reverse transcriptase inhibitors. These block an enzyme that HIV needs to replicate in body cells. When sufficient levels of the drug are present, the virus has more difficulty attaching after contact, and the risk of infection decreases.
- If you are HIV-negative and have an increased risk of sexual HIV transmission
- If you can reliably integrate daily tablet intake into your everyday life
- If you are willing to get tested and examined every 3 months
Anwendung & wichtige HinweiseUse & important informationUtilisation et informations importantesGebruik en belangrijke aandachtspunten
Anwendung:Use:Utilisation :Gebruik: One film-coated tablet daily, preferably at the same time each day and without any gaps in intake. PrEP is intended for use in conjunction with safer sex practices and is monitored through regular testing.
Verfügbare Stärken:Available strengths:Dosages disponibles :Beschikbare sterktes: 200 mg / 245 mg
Only use with a negative HIV test confirmed shortly before starting treatment, as resistance can develop if HIV infection goes undetected. Kidney function and hepatitis B status must be checked beforehand; PrEP does not protect against other sexually transmitted infections.

